top of page

Profile

Join date: Jan 4, 2020

Posts

Apr 20, 2023 ∙ 3 min

BullFrog AI Partners with the Sage Group to Explore JV Opportunities to Advance its Oncology Assets

BullFrog’s oncology assets have been acquired through exclusive licenses with Johns Hopkins University (JHU) and include a Phase 2 ready...

60

0

Feb 1, 2023 ∙ 1 min

The Sage Group advised Zhimeng Biopharma on a worldwide license to GSK of CB06-036, a TLR8 Agonist

In December 2022, GSK entered into an exclusive license agreement with biopharma company Zhimeng for CB06-036, a TLR8 agonist. Subject to...

162

0

Nov 11, 2022 ∙ 2 min

AeroNeph Therapeutics Announces Search for Strategic Partners for Novel Drugs for Renal Disease

Birmingham, Alabama, and London, England, 1 September 2022 – AeroNeph Therapeutics (“AeroNeph”; www.aeroneph.com), a pioneer in discovery...

67

0

B

bil19

Admin

More actions

bottom of page